In 2007，three patents we applied for, which had been firstly checked and substantively reviewed by State Intellectual Property Office for three years, was awarded national invention patent. These three patents were "Reagent kit detecting WFS1 gene mutation related to human hereditary deafness" (Patent No.: ZL200410009112.X), "Gene that inhibits NF-kB and NFAT activation and Polypeptide it encodes" ( Patent No.: ZL200410009098.3), "A tumor-related protein and its encoding gene and application" (Patent No.: ZL200510103026.X).

Over the years we attaches great importance to scientific research work, vigorously carry out enterprise technology innovation, enhance core competitiveness of enterprises at the same time, a profound understanding as to the development of new and high-tech enterprises, with the quantity and quality of patents, has become a measure of corporate competitiveness in the market

At the end of 2007, the company applied 47 patents for inventions: 42 applied to the State Intellectual Property Office, which has authorized three, 17 entered to trial stage, open 13; 5 through PCT channels to foreign patent applications, 1 patent has  authorized in Germany, China and Japan. Patent covers genomics, proteomics, gene function and drug development, gene diagnosis and other biological research field.

We hope that the following research results could be find universities, research institutes, or enterprises to cooperation to achieve industrialization:

(1)The method that detects mutant gene DSPP of dentinogenesis imperfecta
(2)Reagent kit detecting WFS1 gene mutation related to human hereditary deafness
(3)Gene that inhibits NF-kB and NFAT activation and Polypeptide it encodes
(4)A tumor-related protein and its encoding gene and application